	US 11,813,343 B2
	Dentifrice compositions for treatment of dental biofilm
Ross Strand, Singapore (SG); Xiaoxiao Li, Beijing (CN); and Yunming Shi, Beijing (CN)
Assigned to The Procter & Gamble Company, Cincinnati, OH (US)
Filed by The Procter & Gamble Company, Cincinnati, OH (US)
Filed on Sep. 18, 2020, as Appl. No. 17/024,824.
Claims priority of application No. PCT/CN2019/109434 (WO), filed on Sep. 30, 2019.
Prior Publication US 2021/0093526 A1, Apr. 1, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61Q 11/00 (2006.01); A61K 8/21 (2006.01); A61K 8/60 (2006.01); A61K 8/27 (2006.01); A61K 6/00 (2020.01); A61K 8/44 (2006.01); A61K 8/19 (2006.01); A61K 8/25 (2006.01)

CPC A61K 8/27 (2013.01) [A61K 8/19 (2013.01); A61K 8/21 (2013.01); A61K 8/25 (2013.01); A61K 8/44 (2013.01); A61Q 11/00 (2013.01); A61K 2800/30 (2013.01); A61K 2800/48 (2013.01)]

15 Claims

1. A dentifrice composition, comprising:

a) from 0.1% to 0.5%, by weight of the composition, of a zinc ion, the zinc ion comprising zinc lactate;

b) from about 0.1% to about 6%, by weight of the composition, of a glycine or salt thereof, or combination thereof; and

c) from 0.05% to 0.5%, by weight of the composition, of a fluoride ion, wherein the dentifrice composition is substantially free of stannous ion source.